Mikolaj Laszkiewicz

Avatar photo

An experienced journalist and editor passionate about new technologies, computers, and scientific discoveries. He strives to bring a unique perspective to every topic. A law graduate.

Pharmaceutical giant GSK has presented promising Phase I clinical trial results for its targeted ADC therapy (mocertatug rezetecan). The novel drug, aimed at the B7-H4 antigen, demonstrates exceptionally high efficacy against treatment-resistant ovarian cancer and advanced endometrial cancer, paving the way for large-scale Phase III trials later this year.

The government in Athens has announced plans to block access to platforms like TikTok and Instagram for anyone under 15. The Greek prime minister attributes the decision to rising sleep disorders and anxiety among teenagers. Similar steps have long been underway across various US states, where rolling out restrictions continues to face fierce legal pushback rooted in the Constitution.

Imagine a virtual assistant picking out and buying products for you, with the entire transaction happening directly within the AI interface. Visa has unveiled Intelligent Commerce Connect – a new platform that paves the way for AI agents to securely make payments on behalf of consumers, and surprisingly, the system will support more than just Visa cards.

Israeli firm ForSight Robotics has announced the successful completion of the first-ever fully robotic cataract surgery on a human patient. The procedure was performed without the need for general anesthesia, a breakthrough that could radically shift global standards and accessibility in ophthalmic care.